Penumbra Inc

More Details of Penumbra Inc Company

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Company Info

Company codePEN

Company namePenumbra Inc

IPO dateSep 18, 2015

Founded at2004

CEOMr. Adam Elsesser, J.D.

Number of employees4500

Security typeOrdinary Share

Fiscal year-endSep 18

AddressOne Penumbra Place

CityALAMEDA

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code94502

Phone15109952486

Websitehttps://www.penumbrainc.com/

Company codePEN

IPO dateSep 18, 2015

Founded at2004

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Adam Elsesser, J.D.

Chairman of the Board, President, Chief Executive Officer

901.49K

+4.18%

Dr. Arani Bose, M.D.

Director

302.26K

-3.82%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

53.58K

-0.36%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.96K

-1.00%

Ms. Surbhi Sarna

Independent Director

3.15K

-1.84%

Ms. Maggie S. Yuen

Chief Financial Officer

--

Mr. Thomas C. (Tom) Wilder, III

Presiding Independent Director

--

Mr. Harpreet S. Grewal

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Adam Elsesser, J.D.

Chairman of the Board, President, Chief Executive Officer

901.49K

+4.18%

Dr. Arani Bose, M.D.

Director

302.26K

-3.82%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

53.58K

-0.36%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.96K

-1.00%

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

Thrombectomy

815.48M

68.26%

Embolization and Access

379.14M

31.74%

By RegionUSD

Name

Revenue

Proportion

United States

902.07M

75.51%

International

292.55M

24.49%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Thrombectomy

815.48M

68.26%

Embolization and Access

379.14M

31.74%

Shareholder

Update time: Sat, Apr 26

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

Fidelity Management & Research Company LLC

12.53%

The Vanguard Group, Inc.

9.41%

BlackRock Institutional Trust Company, N.A.

9.03%

Champlain Investment Partners, LLC

3.86%

T. Rowe Price Associates, Inc.

3.19%

Other

61.98%

Shareholder Statistics

Shareholder

Proportion

Fidelity Management & Research Company LLC

12.53%

The Vanguard Group, Inc.

9.41%

BlackRock Institutional Trust Company, N.A.

9.03%

Champlain Investment Partners, LLC

3.86%

T. Rowe Price Associates, Inc.

3.19%

Other

61.98%

Type

Shareholder

Proportion

Investment Advisor

50.51%

Investment Advisor/Hedge Fund

32.26%

Hedge Fund

4.42%

Individual Investor

3.42%

Research Firm

1.59%

Pension Fund

1.51%

Sovereign Wealth Fund

0.68%

Bank and Trust

0.54%

Private Equity

0.19%

Other

4.87%

Institutional Shareholding

Update time: Mon, Jan 20

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

838

36.86M

95.18%

-4.14M

2024Q4

834

37.02M

96.10%

-3.78M

2024Q3

813

37.33M

96.12%

-2.93M

2024Q2

796

37.57M

96.93%

+395.13K

2024Q1

777

35.67M

92.18%

-2.09M

2023Q4

759

36.33M

94.13%

-67.98K

2023Q3

737

35.15M

91.46%

-2.09M

2023Q2

719

36.20M

94.64%

-1.94M

2023Q1

681

37.31M

97.62%

-964.82K

2022Q4

661

36.89M

97.22%

+885.45K

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Fidelity Management & Research Company LLC

4.85M

12.6%

-93.71K

-1.89%

Dec 31, 2024

The Vanguard Group, Inc.

3.64M

9.46%

-25.90K

-0.71%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

3.50M

9.08%

+25.93K

+0.75%

Dec 31, 2024

Champlain Investment Partners, LLC

1.50M

3.88%

-52.02K

-3.36%

Dec 31, 2024

T. Rowe Price Associates, Inc.

1.23M

3.21%

-702.67K

-36.27%

Dec 31, 2024

State Street Global Advisors (US)

1.20M

3.12%

-33.45K

-2.71%

Dec 31, 2024

Fidelity Institutional Asset Management

965.15K

2.51%

+16.18K

+1.71%

Dec 31, 2024

Elsesser (Adam)

985.33K

2.56%

+22.75K

+2.36%

Mar 19, 2025

William Blair Investment Management, LLC

883.10K

2.29%

-98.21K

-10.01%

Dec 31, 2024

RTW Investments L.P.

862.45K

2.24%

+66.70K

+8.38%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

Motley Fool Small-Cap Growth ETF

3.6%

First Trust Health Care Alphadex Fund

2.08%

First Trust Indxx Medical Devices ETF

1.89%

Congress SMid Growth ETF

1.87%

Putnam Sustainable Future ETF

1.67%

Tema Neuroscience and Mental Health ETF

1.58%

ROBO Global Healthcare Technology & Innovation ETF

1.56%

SPDR S&P Health Care Equipment ETF

1.53%

Zacks Focus Growth ETF

1.2%

iShares U.S. Medical Devices ETF

1.13%

Motley Fool Small-Cap Growth ETF

Proportion3.6%

First Trust Health Care Alphadex Fund

Proportion2.08%

First Trust Indxx Medical Devices ETF

Proportion1.89%

Congress SMid Growth ETF

Proportion1.87%

Putnam Sustainable Future ETF

Proportion1.67%

Tema Neuroscience and Mental Health ETF

Proportion1.58%

ROBO Global Healthcare Technology & Innovation ETF

Proportion1.56%

SPDR S&P Health Care Equipment ETF

Proportion1.53%

Zacks Focus Growth ETF

Proportion1.2%

iShares U.S. Medical Devices ETF

Proportion1.13%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

297.577USD

Penumbra Inc

297.577

Overview

Company